Menicon Company (7780) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 May, 2026Market overview and trends
Vision care accounts for 92.8% of consolidated sales, with healthcare and life care at 7.2%.
The global myopia population is rising, projected to reach 5 billion by 2050.
The Japanese contact lens market reached JPY 316.0 billion in FY2025, with a 20% group share.
1-DAY lenses represent 26.9% of sales, with lens care products at 54.3%.
The global contact lens market is expanding, with increasing 1-DAY lens adoption.
Business model and growth strategy
MELS Plan subscription model offers fixed monthly fees and flexible lens replacement.
MELS Plan members reached 1.346 million in FY2025, with a growing share of high-value 1-DAY lens users.
Monthly fees for 1-DAY lenses range from JPY 4,600 to 5,900.
Sales channels include 1,641 MELS Plan member shops as of March 2026.
Key success factors include strong global demand for 1-DAY lenses and growth in orthokeratology in Asia.
Product and production expansion
Expanding 1-DAY lens sales globally, with new production at Malaysia, Singapore, and Japan plants.
Product lineup includes silicone hydrogel, toric, multifocal, and color lenses.
Innovative packaging design enables hygienic and easy lens handling.
Orthokeratology lenses promoted globally, with tailored strategies for China, Asia, and Western markets.
Production bases span Japan, Europe, China, Singapore, Malaysia, and Italy.
Latest events from Menicon Company
- Sales and profits rose on strong daily disposable lens demand and global expansion.7780
Q4 202613 May 2026 - Profit and sales rose, driven by daily disposable lens growth and global expansion.7780
Q3 202613 Feb 2026 - 1-DAY lens sales and price hikes lifted sales, but profits fell on higher costs and FX losses.7780
Q2 202614 Nov 2025 - Profits fell sharply despite stable sales, as investments and FX losses weighed on margins.7780
Q1 20268 Aug 2025 - Sales and profits rose on strong lens demand, with margin pressure expected ahead.7780
Q2 202513 Jun 2025 - Sales and profit rose on Vision Care strength, with robust full-year outlook maintained.7780
Q1 202513 Jun 2025 - Profit and sales surged on daily lens demand; growth to continue with new capacity and expansion.7780
Q4 20256 Jun 2025 - Profits rose on lens demand and price hikes, but China remains a challenge.7780
Q3 20255 Jun 2025